Buy Ritter Pharmaceuticals Stock | RTTR Stock Price & Latest News | Public
RTTR

Ritter Pharmaceuticals

    We couldn’t load this chart.

    Some stock charts might currently not be supported. To try again, please refresh this page.

    About RTTR

    Ritter Pharmaceuticals, Inc. engages in the development of novel therapeutic products which modulate the human gut microbiome to treat digestive disorders and gastrointestinal diseases. It focuses on the development and commercialization of RP-G28. The company was found...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    -0.58
    -1.1
    -1.61
    -2.12
    Q4 2019
    Q1 2020
    Q2 2020

    Expected EPS
    Q2 2020

    -$2.12

    Actual EPS
    Q2 2020

    -$2.12

    Stats

    Market Cap$93,99M
    Volume
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$21.50
    1 Year Low$3.71
    Open
    High
    Low

    Buy any stock with any amount of money.

    Download the App
    Download the app